Microarray, a miniaturized glass slide or membrane with immobilized DNA probes, is a powerful tool for the analysis of mutations, gene expression and sequencing. This technique requires chip (glass slide or membrane) fabrication, preparation of probes and labelled targets, hybridization and data analysis. Microarrays give the possibility to evaluate a wide spectrum of candidate genes, to simultaneously observe interaction of genes, to detect polymorphisms within genes and identify therapeutic targets. Coronary artery disease being a major cause of death, is a disorder influenced by either genetic or environmental factors. Microarray analysis of gene expression can be used to identify genes involved in disease progression and in disease reduction. Chips also allow for the throughput and simultaneous analysis of a great variety of cell types such as cardiomyocytes, monocytes, macrophages, smooth muscle, endothelial, and fibroblasts and chemical mediators involved in cardiovascular disease pathology, their interactions and cumulative effects.
Contents
-
February 11, 2009
-
February 11, 2009
-
February 11, 2009
-
Open AccessMarkers of oxidative stress in acute myocardial infarction treated by percutaneous coronary interventionFebruary 11, 2009
-
Open AccessCoronary artery atherosclerosis in patients with the initial and the early stage of chronic renal failureFebruary 11, 2009
-
February 11, 2009
-
Open AccessComplications during pregnancy, labor and puerperium in women with increased BMI at pregnancy termFebruary 11, 2009
-
February 11, 2009
-
Open AccessComparision of the effects of subtenon’s and subconjunctival anesthesia on retroorbital hemodynamicsFebruary 11, 2009
-
February 11, 2009
-
Open AccessSerum neopterin in workers exposed to inorganic dust containing free crystalline silicon dioxideFebruary 11, 2009
-
February 11, 2009
-
February 11, 2009
-
February 11, 2009
-
February 11, 2009
-
February 11, 2009
-
Open AccessRecurrent suprapubic abscess and vaginal fistula after anterior intravaginal slingplastyFebruary 11, 2009
-
Open AccessHepatocellular carcinoma in Central, Eastern, and Southern Europe. What Future after the SHARP Trial?February 11, 2009